Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Total Liabilities: 2017-2024

Historic Total Liabilities for Bicycle Therapeutics (BCYC) over the last 8 years, with Dec 2024 value amounting to $163.8 million.

  • Bicycle Therapeutics' Total Liabilities fell 12.21% to $145.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.5 million, marking a year-over-year decrease of 12.21%. This contributed to the annual value of $163.8 million for FY2024, which is 27.01% down from last year.
  • Per Bicycle Therapeutics' latest filing, its Total Liabilities stood at $163.8 million for FY2024, which was down 27.01% from $224.4 million recorded in FY2023.
  • Bicycle Therapeutics' Total Liabilities' 5-year high stood at $224.4 million during FY2023, with a 5-year trough of $65.7 million in FY2020.
  • Moreover, its 3-year median value for Total Liabilities was $163.8 million (2024), whereas its average is $176.0 million.
  • In the last 5 years, Bicycle Therapeutics' Total Liabilities spiked by 286.51% in 2020 and then decreased by 27.01% in 2024.
  • Bicycle Therapeutics' Total Liabilities (Yearly) stood at $65.7 million in 2020, then skyrocketed by 103.28% to $133.5 million in 2021, then increased by 4.71% to $139.8 million in 2022, then soared by 60.49% to $224.4 million in 2023, then decreased by 27.01% to $163.8 million in 2024.